Hiatal Hernia and Acid Reflux Frequency Predict Presence and Length of Barrett's Esophagus
暂无分享,去创建一个
[1] E. Kuipers,et al. Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study , 1999, Gut.
[2] A. Cameron. Barrett's esophagus: prevalence and size of hiatal hernia , 1998, American Journal of Gastroenterology.
[3] D. Schaid,et al. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. , 1997, Gastroenterology.
[4] M. Helfand,et al. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. , 1997, The American journal of gastroenterology.
[5] R. Sampliner,et al. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. , 1997, The American journal of gastroenterology.
[6] M. Omary,et al. Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. , 1996, The Journal of clinical investigation.
[7] G. Lapertosa,et al. Time pattern of gastric acidity in Barrett's esophagus , 1996, Digestive Diseases and Sciences.
[8] B. Hirschowitz. Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls , 1996, Digestive Diseases and Sciences.
[9] R. Goyal,et al. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. , 1996, Gastroenterology.
[10] R. Sampliner. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. , 1994, The American journal of gastroenterology.
[11] J. Richter,et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. , 1994, Gastroenterology.
[12] N. Shepherd,et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy , 1993, Alimentary pharmacology & therapeutics.
[13] E. Hassall. Barrett's esophagus: congenital or acquired? , 1993, The American journal of gastroenterology.
[14] A. Cameron,et al. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. , 1992, Gastroenterology.
[15] D. Johnson,et al. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus , 1992, Digestive Diseases and Sciences.
[16] C D Schleck,et al. Dyspepsia and dyspepsia subgroups: a population-based study. , 1992, Gastroenterology.
[17] R. Hinder,et al. Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus. , 1989, Surgery.
[18] M. Mulholland,et al. Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium , 1989, Digestive Diseases and Sciences.
[19] P J Kahrilas,et al. Esophageal peristaltic dysfunction in peptic esophagitis. , 1986, Gastroenterology.
[20] D. Graham,et al. Why do apparently healthy people use antacid tablets? , 1983, The American journal of gastroenterology.
[21] D. Skinner,et al. Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. , 1983, Archives of surgery.
[22] E. Schimmel,et al. Revised radiologic concepts of the Barrett esophagus , 1978, Gastrointestinal Radiology.
[23] T. Holder. Columnar cell-lined esophagus: Assessment of etiology and treatment , 1976 .
[24] J. Borrie,et al. Columnar cell-lined esophagus: assessment of etiology and treatment. A 22 year experience. , 1976, The Journal of thoracic and cardiovascular surgery.
[25] Johnson Lf,et al. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. , 1974 .
[26] M. Aickin,et al. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients , 2005, Digestive Diseases and Sciences.
[27] J. Siewert,et al. Barrett's esophagus: Pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management , 2005, Dysphagia.
[28] P. Dítě,et al. [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.
[29] R. Sandler,et al. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. , 1997, The American journal of gastroenterology.
[30] J. Mold,et al. Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. , 1991, The American journal of gastroenterology.
[31] David F. Cruess,et al. Barrett's esophagus: A prevalent, occult complication of gastroesophageal reflux disease , 1987 .
[32] J. Cameron,et al. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. , 1985, American journal of surgery.